Mavacamten Impurity 17 | CAS 2384975-66-8 - Request Quote
Mavacamten Impurity 17
| SZ CAT No: | SZ-M132018 |
| CAS No | 2384975-66-8 |
| Mol.F. | C14H17N3O2 |
| Mol.Wt. | 259.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Mavacamten Impurity 17 is chemically 6-(Benzylamino)-3-isopropylpyrimidine-2,4(1H,3H)-dione. Mavacamten Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Mavacamten Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mavacamten.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2384975-66-8
Purchase 2384975-66-8
Order 2384975-66-8
Enquire 2384975-66-8
price of 2384975-66-8
2384975-66-8 Supplier
2384975-66-8 Manufacturer
2384975-66-8 Exporter
buy high quality Mavacamten Impurity 17
Purchase Mavacamten Impurity 17
Mavacamten Impurity 17 suppliers
Mavacamten Impurity 17 manufacturers
Mavacamten Impurity 17 price
Order Mavacamten Impurity 17
Enquire Mavacamten Impurity 17
Mavacamten Impurity 17 cost
Mavacamten Impurity 17 Supplier
Mavacamten Impurity 17 Distributor
Mavacamten Impurity 17 for Method Validation
Mavacamten Reference Standard
Mavacamten Impurity 17 for ANDA Filing
Mavacamten Impurity 17 for Forced Degradation Studies
Mavacamten Impurity 17 Identification Standards
Mavacamten Impurity 17 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.